Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD
Vlad Ratziu, Jérôme Boursier, Victor de Lédinghen, Rodolphe Anty, Charlotte Costentin, Christophe Bureau
Topics & Concepts
Fatty liverBiomarkerDiseaseMedicinePopulationSteatosisRisk factorMetabolic syndromeClinical phenotypeHepatic dysfunctionPhenotypeInternal medicineBioinformaticsBiologyObesityGeneEnvironmental healthBiochemistryLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseLipid metabolism and disorders